Peer Review History

Original SubmissionMarch 26, 2025
Decision Letter - Janin Nouhin, Editor

Dear Dr. Nguyen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Janin Nouhin, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Thank you for stating the following financial disclosure: [This work was part of the CGIAR initiative on One Health, which was supported by contributors to the CGIAR Trust Fund (https://www.cgiar.org/funders). In addition, JFL’s time was funded by FORMAS (2021–00833), HSL's time was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (RS-2022-NR068754).]. 

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We note that Figures 1 and 3 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figures 1 and 3 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors report on a cross-sectional study of exposure to hantavirus and hepatitis E among farmworkers in two provinces in Vietnam. Along with reporting seroprevalence, they also report risk factors for exposure and found that gender, age, ethnicity, geography, and behaviors associated with greater wildlife interaction were associated with seropositivity. This study has the potential to make a useful contribution to the study of hantavirus and HEV within a One Health framework, but several key issues need to be addressed.

Major Comments

1. A major aim of the study is to assess risk factors for hantavirus and HEV, but the introduction contains minimal discussion of what we know about risk factors for these specific viruses from prior studies in other settings. The paper would be strengthened if this prior work were discussed in the introduction and used to motivate the key variables that the authors include in their analysis: age, gender, geography, and behaviors that lead people to interact more closely with wildlife. The authors provide a rich discussion of these risk factors in the discussion and could use some of these details as background and motivation for the analysis.

2. Backward selection can often lead to false positives (Type I errors) and can also fail to identify important predictors that might be excluded during the selection process. I suggest the authors consider fitting their model with all the predictor variables they think important for understanding infection patterns and base their inference on that complete model. This paper provides more detail on issues with stepwise model fitting:

Mundry, R., & Nunn, C. L. (2009). Stepwise model fitting and statistical inference: turning noise into signal pollution. The American Naturalist, 173(1), 119-123.

Minor Comments

Abstract

1. Line 26: Report the type of blood sample.

2. Line 36: Clarify the reference category for “wildlife farming activities only.”

Introduction

1. The last paragraph mentions the “distinct wildlife trade dynamics” of Lao Cai and Dong Nai. It would be helpful to have some description of these dynamics here in the Introduction. How do the two regions differ and how might these differences affect exposure?

Methods

1. What percent of farms in Dong Nai were recruited for the study? What were the characteristics of the farms selected for the study?

2. It is unclear how many participants were recruited from each farm. Were the samples relatively similar across farms? If not, how did they differ?

3. Did the authors consider another level of nestedness in their model for farm? It is unclear how many participants were recruited from each farm, but a three-level model with both farm and province as random effects might be appropriate.

Discussion:

1. Lines 450-452: Please include a reference for this statement (if possible): "In Vietnam, it is very common that local people consume uncooked wild meat and wildlife Products as they believe in the health benefits and exoticism of wild meat."

Reviewer #2: Nguyen et al. investigated antibody prevalence and risk factors of wildlife farmers (keeping wild boars, civets, bamboo rats or bats) for infections with hantavirus or hepatitis E virus (HEV) in Vietnam. About 200 wildlife farmers from 2 distant regions in Vietnam participated in the study. Hantavirus IgG was detected in 8.7 %, hantavirus IgM in 1.9% and HEV-specific IgG in 26.7% of tested persons. The only identified risk factor for hantavirus infection was wildlife farming activities, whereas for HEV infection men gender, older age, consumption of raw meat and residing in higher altitudes were identified as risk factors. Somewhat surprisingly, use of protective clothing was also identified as HEV risk factor. The authors conclude that improved biosecurity, proper hygiene practise and surveillance activities are necessary to prevent infections with hantavirus and HEV in future.

General Comments:

Investigation on risk factors for specific infections are of general importance for risk mitigation strategies to prevent disease in future. The two analyzed viruses – hantavirus and HEV – are important zoonotic antigens and wildlife farmers are generally considered to be of risk of these zoonotic infections. Although the results of the study are mainly of confirmational nature, the data are of general interest and might contribute to further develop specific prevention strategies. However, several aspects need to be addressed before publication of the manuscript.

First of all, the transmission pathways of HEV are insufficiently described, which might result in misinterpretation of findings. HEV can be grouped into four main human-pathogenic genotypes, of which only genotypes 3 and 4 are zoonotic and infect animals, especially pigs and wild boars. In contrast, genotypes 1 and 2 only infect humans and cannot be zoonotically transmitted. It is therefore misleading to include case numbers, which are derived from genotype 1 and 2 infection (see Ref. 26), directly before mentioning animal infections (lines 67-71), and mix all together. The situation is even more complicated as another different virus species, ratHEV, can infect rats and in some cases zoonotically transmitted to humans. Therefore:

- these genotypes/virus species, their transmission pathways and reservoirs has to be described in more detail

- the situation regarding the presence of these genotypes and ratHEV in Vietnam should be mentioned

- the specificity of the applied serologic test for detecting antibodies of the different HEV genotypes/virus species has to be included

- it would also be important to discuss the results in light of the genotypes/virus species host specificity, e.g. by comparing farmers keeping wild boar or bamboo rats vs. those keeping civets or bats.

The discussion is very long, also repeating already mentioned facts (e.g., in 1st paragraph) and should be condensed to the necessary information.

Additional specific comments:

- L. 26: It would be helpful to insert the animal species kept by the farmers (bats, bamboo rats, civets, wild boars) into the abstract.

- L. 40-41: An explanation on the finding with the protective clothing should be inserted as the conclusions (improved biosecurity, proper hygiene, …) are confusing as they stand now. Please insert “…although their proper use was not assessed” in l. 41, or similar.

- L. 65-71: see General Comments on HEV genotypes and species, their animal reservoirs, transmission pathways and occurrence in Vietnam.

- L. 187-191: see General Comments on specificity of the test for HEV genotypes and species.

- L. 282: read … (IgG and/or IgM) …

- L. 382-383: Has there been an increased number of illnesses in the Dong Nai province, which might indicate a hantavirus outbreak?

- L. 399-406: see General Comments on HEV genotypes/species and animal reservoirs.

- L. 407-408: it should be considered that antibodies can persist for more than one year. Therefore, they might originate from illness a longer time ago.

- L. 413-418: Did the hantavirus IgM-positive persons reported hantavirus-specific symptoms?

- L. 428: Please specify if “affected by HEV” relates to HEV infection or HEV-induced disease.

- L. 487-504: Please include in discussion the finding of Ref. 72, which described evidence for the benefit of protective gloves during disemboweling of wild boars, for preventing HEV infection.

- l. 513: see General Comments on HEV genotypes and species and their transmission pathways.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

We thank the reviewers and editors for their constructive feedback. A detailed, point-by-point Response to Reviewers and Editors document has been attached to this submission to address all comments raised.

Should you require any further clarifications or revisions, please do not hesitate to let us know.

Attachments
Attachment
Submitted filename: Response to Editors and Reviewers.docx
Decision Letter - Janin Nouhin, Editor

Seroprevalence and risk factors of hantavirus and hepatitis E virus exposure among wildlife farmers in Vietnam

PONE-D-25-15935R1

Dear Dr. Nguyen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Janin Nouhin, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Janin Nouhin, Editor

PONE-D-25-15935R1

PLOS ONE

Dear Dr. Nguyen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Janin Nouhin

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .